Also, inhibition of mTOR is shown to reduce the production of dnT cells and favors the expansion of therapeutic CD4+CD25+Foxp3+ Treg cells in lupus-prone mice and SLE patients (30–32). This evidence concerns the gene CD4 and systemic lupus erythematosus.